Neumora Therapeutics (NMRA) Other Non Operating Income (2022 - 2026)
Neumora Therapeutics (NMRA) recorded quarterly Other Non Operating Income of $59000.0 in Q1 2026, up 121.93% quarter-over-quarter from -$269000.0 in Q4 2025, and up 336.0% on a YoY basis from $13532.1 in Q1 2025.
Neumora Therapeutics (NMRA) Other Non Operating Income (2022 - 2026) Analysis & Trends
Neumora Therapeutics' Other Non Operating Income history runs 5 years deep, the most recent figure standing at $59000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 336.0% year-over-year to $59000.0; the TTM figure through Mar 2026 stood at -$683000.0 (down 650.55% YoY), while the FY2025 annual figure was -$767000.0, down 883.33% from the prior year.
- Other Non Operating Income was $59000.0 for Q1 2026 at Neumora Therapeutics, up from -$269000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $287000.0 in Q4 2022 to a low of -$480000.0 in Q2 2025.
- Historically, Other Non Operating Income has averaged -$54466.7 across 5 years, with a median of -$25000.0 in 2025.
- The sharpest annual moves came in 2024 and 2026: Other Non Operating Income slumped 5600.0% in 2024, then soared 336.0% in 2026.
- A 5-year view of Other Non Operating Income shows it stood at $287000.0 in 2022, then slumped by 136.24% to -$104000.0 in 2023, then soared by 114.42% to $15000.0 in 2024, then plunged by 1893.33% to -$269000.0 in 2025, then surged by 121.93% to $59000.0 in 2026.
- The last three Other Non Operating Income figures came in at $59000.0 (Q1 2026), -$269000.0 (Q4 2025), and $7000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Neumora Therapeutics | 320.17 Mn | 320.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59,000.00 |
| Dec 31, 2025 | -269,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | -480,000.00 |
| Mar 31, 2025 | -25,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Sep 30, 2024 | -57,000.00 |
| Jun 30, 2024 | -24,000.00 |
| Mar 31, 2024 | -12,000.00 |
| Dec 31, 2023 | -104,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -39,000.00 |
| Mar 31, 2023 | -26,000.00 |
| Dec 31, 2022 | 287,000.00 |
| Sep 30, 2022 | -148,000.00 |